Is it too soon for Mesenchymal Stem Cell trials in people with ALS?

Amyotrophic Lateral Sclerosis

Volumn 9, Issue 6, 2008, Pages 321-322

  Badayan, Irina ^a   Cudkowicz, Merit ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Amyotrophic Lateral Sclerosis; Clinical Trials; SOD1; Therapy

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN DEGENERATION; CELL ACTIVATION; CELL DIFFERENTIATION; CLINICAL TRIAL; DISEASE COURSE; FETAL TISSUE TRANSPLANTATION; GENETIC HETEROGENEITY; GRAFT SURVIVAL; HIGH RISK PATIENT; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROGLIA; MORTALITY; MOTOR NEURON DISEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SAFETY; SHAM PROCEDURE; SURVIVAL TIME; TREATMENT RESPONSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; PILOT PROJECTS; TIME FACTORS;

EID: 54049157847     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/17482960802425559     Document Type: Review

References (11)

1. Mazzini, L., Mareschi, K., Ferrero, I., Vassallo, E., Oliveri, G. Nasuelli, N. et al. (2008) Stem cell treatment in Amyotrophic Lateral Sclerosis. J Neurol Sci, 265, pp. 78-83.
2. Vercelli, A., Garbossa, D., Mereuta, M., Muraca, G., Mareschi, K. Rustichelli, D. et al. (2006) Transplantation of human mesenchymal stem cells into the lumbar spinal cord of G93A mice (abstract).
3. Vercelli, A., Mereuta, OM, Garbossa, D., Muraca, G., Mareschi, K. Rustichelli, D. et al. (2008) Human mesenchymal stem cell transplantation extends survival, improved motor performance and decreases neuroinflamation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis
4. Cashman, N., Tan, L., Krieger, C., Madler, B., Mackay, A. Mackensie, I. et al. (2008) Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS). Muscle Nerve, 37, pp. 620-625.
5. Kim, SYH, Frank, S., Holloway, R., Zimmerman, C., Wilson, R. and Kieburtz, K. (2005) Science and ethics of Sham Surgery. Arch Neurol., 62, pp. 1357-1360.
6. Frank, S., Wilson, R., Holloway, R., Zimmerman, C., Peterson, DR Kieburtz, K. et al. (2007) Ethics of sham surgery: Perspective of patients. Mov Disord, 23:1, pp. 63-38.
7. Polgar, S. and Ng, J. (2007) A critical analysis of evidence for using sham surgery in Parkinson's disease: Implications for public health. Aust N Z J Public Health, 31:3, pp. 270-274.
8. Clarkson, E. and Freed, C. (1999) Development of Fetal Neural Transplantation As A Treatment For Parkinson's Disease. Life Sci, 65:23, pp. 2427-2437.
9. Freed, CR, Greene, PE, Breeze, RE, Tsai, W-Y, DuMouchel, W. Kao, R. et al. (2001) Transplantation of Embryonic Dopamine Neurons For Severe Parkinson's Disease. N Engl J Med, 344:10, pp. 710-719.
10. Olanow, CW, Goetz, CG, Kordower, JH, Stoessl, AJ, Sossi, V. Brin, MF et al. (2003) A Double-blind Controlled Trial of Bilateral Fetal Nigral Transplantation in Parkinson's Disease. Ann Neurol, 54, pp. 403-414.
11. Fischbach, G. and McKhann, G. (2001) Cell Therapy for Parkinson's Disease. N Engl J Med, 344:10, pp. 763-765.